Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118994240B reveals novel bisphenol-derived ligands enabling ortho-functionalization for enhanced hydroformylation and hydroesterification efficiency.
Patent CN114805031A reveals efficient aryl halide hydroxylation using recyclable CuPc catalysts, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed method for sulfinyl compounds offers high yield and functional tolerance. Enhances supply chain reliability for pharmaceutical intermediate manufacturing.
Discover the novel Ir-catalyzed asymmetric synthesis of colchicine from isovanillin. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Patent CN114890913B reveals a high-yield synthesis of dicyanoethyl cyclohexylamine using recyclable acidic ionic liquids, ensuring ultra-low acid content for downstream hydrogenation.
Novel visible-light method for 1,2-allenyl ketones offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply chains.
Patent CN104710315A reveals ionic liquid microwave method. High yield, eco-friendly. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN103214452B details a novel iron-mediated reduction route for duloxetine intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel ruthenium catalyst method for ceramide intermediates. High stereoselectivity and reduced reaction time for supply chain efficiency.
Patent CN111203276B reveals a manganese-catalyzed hydrosilylation method for high-purity chiral silanes, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN114480315B reveals a novel Baeyer-Villiger monooxygenase route for brivaracetam synthesis offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102267973B details a novel artemisinin intermediate synthesis using hydrogen peroxide, offering significant cost reduction and scalability advantages for pharmaceutical manufacturing.
Patent CN104250236A details efficient CuH catalyzed lactone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113024479B reveals a green synthesis route for Clomazone using ether catalysts and water solvent, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Novel solid catalyst method reduces bromine use and improves purity for difenoconazole intermediate manufacturing supply chains.
Patent CN114014766A reveals a safer Houben-Hoesch route for dopamine intermediates, eliminating noble metals and toxic cyanides for cost-effective manufacturing.
Patent CN120623030A enables green 1,3-diketone synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel catalytic method for 3,3'-bisindole synthesis offers significant cost reduction and scalable manufacturing capabilities for the global pharmaceutical intermediates supply chain.
Patent CN107382874A details high-yield synthesis of chiral NHC salts. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN110117254B reveals a streamlined 3-step route for Cabozantinib, replacing hazardous nitration with efficient one-pot reduction and copper-catalyzed decarboxylation for superior supply chain stability.